BREAKING
Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 hour ago Abbott reports positive results from study on its atrial fibrillation therapies 2 hours ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Major Pharmaceutical Merger Announced: $50B Deal Reshapes Industry 1 week ago Retail Sales Beat Expectations, Consumer Spending Remains Strong 1 week ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 hour ago Abbott reports positive results from study on its atrial fibrillation therapies 2 hours ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Major Pharmaceutical Merger Announced: $50B Deal Reshapes Industry 1 week ago Retail Sales Beat Expectations, Consumer Spending Remains Strong 1 week ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago
ADVERTISEMENT

NTNX Earnings: Key highlights from Nutanix Q3 2020 results

Nutanix (NASDAQ: NTNX) today announced its third quarter financial results for the period ended April 30, 2020. NTNX reported net loss of $240.7 million, or $1.23 per share, compared to a net loss of $209.8 million, or $1.15 per share in the third quarter of 2019. Revenues increased 11% to $318.3 million. You may also […]

May 27, 2020 1 min read

Nutanix (NASDAQ: NTNX) today announced its third quarter financial results for the period ended April 30, 2020.

NTNX reported net loss of $240.7 million, or $1.23 per share, compared to a net loss of $209.8 million, or $1.15 per share in the third quarter of 2019.

Revenues increased 11% to $318.3 million.

You may also like:

ADVERTISEMENT